Indo-Bangla Pharmaceuticals Limited (DSE: IBP)

IBP Revenue

Indo-Bangla Pharmaceuticals had revenue of 19.11M BDT in the quarter ending March 31, 2024, a decrease of -81.52%. This brings the company's revenue in the last twelve months to 211.61M, down -43.54% year-over-year. In the fiscal year ending June 30, 2023, Indo-Bangla Pharmaceuticals had annual revenue of 374.48M, down -22.74%.

• Revenue (ttm): 211.61M
• Revenue Growth: -43.54%
• P/S Ratio: 4.64
• Revenue / Employee: 1.09M
• Employees: 194
• Market Cap: 1.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	374.48M	-110.20M	-22.74%
Jul 1, 2022	484.68M	-297.56M	-38.04%
Jul 1, 2021	782.24M	-83.86M	-9.68%
Jun 30, 2020	866.10M	125.38M	16.93%
Jun 30, 2019	740.71M	80.74M	12.23%